THE PERIPHERAL blood changes associated with cirrhosis and splenomegaly were first described by Banti in 1894 . This is often known as hypersplenism and essentially consists of thrombocytopenia and less frequently neutropenia and anaemia. Neutropenia
The neutropenia is mild, in the region of 2000-4000 cells/mm3 and was found to be present in forty of eighty patients with subacute or chronic liver disease (Meulengracht & Gormsen, 1948) . There was no deviation from the normal differential count. The neutropenia would appear to be a function of portal hypertension and splenomegaly since neutropenia of this order was present in seventeen out of twenty-one patients with extrahepatic portal hypertension (Stathers, Ma & Blackburn, 1968 Welch, (1950) . Unfortunately it has been difficult to study neutrophil kinetics except in patients in the terminal stages of their illness (Cronkite et al., 1958; Godwin, Zimmerman & Perry, 1968) . The most satisfactory neutrophil isotope label, tritiated thymidine (Cronkite et al., 1959 ) cannot be used due to the high irradiation dose to individual cells (Robertson & Hughes, 1958) . Thrombocytopenia In 1929 King found that in 20% of cirrhotic patients the platelet count was decreased although in only two out of fifteen patients were the bleeding and clotting times prolonged. Morlock & Hall (1943) in a survey of eighty consecutive patients with cirrhosis found that 175 % has a platelet count of less than 100,000/mm3, although in only two patients was the count less than 50,000/mm3. When the patients were divided into two groups, those with and those without gastro-intestinal bleeding, the incidence of thrombocytopenia was 25 and 6%, respectively. In seventeen out of twenty-one patients with extrahepatic portal hypertension already referred to the platelet count ranged from 21,000 to 146,000/mm3 (Stathers et al., 1968) .
The mechanism of thrombocytopenia associated with hypersplenism has recently been studied by Aster (1966) 
Recovery in the general circulation of 6'Crlabelled platelets transfused to asplenic, normal, and splenomegalic subjects. 'Recovery' is the percentage of platelets remaining in the general circulation 2 hr after injection [From Aster (1966) Pitcher & Williams (1963) by demonstrating that red cells from cirrhotic patients still had a reduced survival in 'normal subjects' and by the finding of low levels of reduced glutathione in the red cell in the majority of patients studied. This is known to be the mechanism in patients with certain types of drug-induced haemolytic anaemias (Beutler, 1957) but Pitcher & Williams (1963) were not able to show a correlation between this defect and the degree of haemolysis.
The presence of an extrinsic haemolytic mechanism was suggested by Jandl (1955) Pryor (1967) in patients with tropical splenomegaly. Using an external radioactive counter over the spleen a marked delay in reaching a plateau recording was seen due to the presence of a slow-mixing red cell pool (Fig. 2) . This finding was confirmed by Toghill (1964) who showed that producing splenic contraction by intravenous noradrenaline infusion resulted in a diminution of the red cell pool with subsequent rise in the packed cell volume. In contrast to platelet sequestration, pooling of red cells within the spleen results in damage to the red cell membrane and a shortening of their life span (Prankerd, 1963) . However, this phenomenon has been more difficult to demonstrate in cirrhotic patients.
The other major cause of anaemia in cirrhosis due to hyperspenism is an enlarged plasma volume causing haemodilution. Using 125I-labelled human serum albumin we have measured the plasma volume of thirty-four cirrhotic patients and 70-6% had an enlarged plasma volume, that is greater than 50 ml/kg body weight (Fig. 3) . In other studies this figure has varied from 11 % (Boivin, Hartmann & Fauvert, 1961) to 80% (McFadzean & Todd, 1967) . Some doubt has been expressed as to whether markers dependent on the distribution of albumin are true indicators of the volume of plasma in cirrhotic patients (Peters, 1948) . Lieberman & Reynolds (1967) have shown, however, that leakage of labelled albumin into the lymphatics, the suggested source of the error with this method, resulted in a maximum activity of only 0-8 % of that of plasma. McFadzean & Todd (1967) found that expansion of plasma volume could be related to the degree of splenic enlargement although Kimber and his coworkers (1965) found no association with splenomegaly. Our results so far support the view that enlargement of the spleen is associated with increase in plasma volume (Blendis, Toghill & Williams, 1968) . However, the presence of portal hypertension has also been implicated by the finding of a correlation with the wedged hepatic vein pressure (Lieberman & Reynolds, 1967) and by an approximate relationship with the presence of portal venous collaterals with their increased vascular capacity (Eisenberg, 1956) . (1963) and that for plasma volume is taken from Gibson & Evans (1937) . The continuous line is from published information and is that given by Mollison (1967) . 0, Cirrhosis; 0, controls.
Indications for splenectomy Since the effects of hypersplenism in cirrhosis are usually mild, splenectomy is seldom indicated. The serious degree of neutropenia seen in the hypersplenism of Felty's syndrome is extremely rare in cirrhosis. Although splenectomy will cause a remission in the neutropenia it will not alter the ultimate prognosis in these patients (Poinso et al., 1958) . Thrombocytopenia in cirrhosis rarely presents an haemorrhagic hazard. However severe thrombocytopenia in cirrhosis, with purpura, has been reported and in these cases splenectomy brought about a complete remission (Morlock & Hall, 1943) . The haemolysis of hypersplenism or the dilutional effect of an expanded plasma volume are rarely serious enough to warrant splenectomy. When this was performed the red cell mass increased due to correction of haemolysis and although the plasma volume decreased it remained elevated in twelve out of fourteen patients (McFadzean & Todd, 1967) .
Splenectomy should be performed in association with a splenorenal shunt if there is evidence of portal hypertension, since the propagation of thrombus within the splenic vein into the hepatic portal vein, which happens not infrequently, will render future shunt operations impossible. The problem of an increased risk of infection after splenectomy that occurs in children (Eraklis et al., 1967) is not present to such an extent in adults.
